For further information contact Paul Coghlan at Linear Technology Corporation, 1630 McCarthy Blvd., Milpitas, California 95035-7417, (408) 432-1900.
LINEAR TECHNOLOGY CORPORATION CONSOLIDATED STATEMENTS OF INCOME (In thousands, except per share amounts) U.S. GAAP (unaudited) |
|||||||||||||||||
Three Months Ended | Six Months Ended | ||||||||||||||||
December 28,
2014 |
September 28,
2014 |
December 29,
2013 |
December 28,
2014 |
December 29,
2013 |
|||||||||||||
Revenues | $ | 352,575 | $ | 371,060 | $ | 334,595 | $ | 723,635 | $ | 674,952 | |||||||
Cost of sales (1) | 86,726 | 89,007 | 82,521 | 175,733 | 166,522 | ||||||||||||
Gross profit | 265,849 | 282,053 | 252,074 | 547,902 | 508,430 | ||||||||||||
Expenses: | |||||||||||||||||
Research and development (1) | 65,101 | 65,600 | 62,008 | 130,701 | 123,520 | ||||||||||||
Selling, general and administrative (1) | 42,537 | 42,089 | 38,852 | 84,626 | 77,530 | ||||||||||||
Total operating expenses | 107,638 | 107,689 | 100,860 | 215,327 | 201,050 | ||||||||||||
Operating income | 158,211 | 174,364 | 151,214 | 332,575 | 307,380 | ||||||||||||
Interest expense | — | — | (6,813 | ) | — | (13,626 | ) | ||||||||||
Amortization of debt discount (2) | — | — | (5,524 | ) | — | (10,970 | ) | ||||||||||
Interest income and other income | 253 | 581 | 791 | 834 | 1,673 | ||||||||||||
Income before income taxes | 158,464 | 174,945 | 139,668 | 333,409 | 284,457 | ||||||||||||
Provision for income taxes | 34,862 | 45,486 | 34,917 | 80,348 | 71,838 | ||||||||||||
Net income | $ | 123,602 | $ | 129,459 | $ | 104,751 | $ | 253,061 | $ | 212,619 | |||||||
Earnings per share: | |||||||||||||||||
Basic | $ | 0.51 | $ | 0.53 | $ | 0.44 | $ | 1.04 | $ | 0.89 | |||||||
Diluted | $ | 0.51 | $ | 0.53 | $ | 0.44 | $ | 1.03 | $ | 0.89 | |||||||
Shares used in determining earnings per share: | |||||||||||||||||
Basic | 244,033 | 244,145 | 239,206 | 244,067 | 238,857 | ||||||||||||
Diluted | 244,591 | 244,801 | 240,670 | 244,674 | 240,000 | ||||||||||||
Includes the following non-cash charges: | |||||||||||||||||
(1) Stock-based compensation | |||||||||||||||||
Cost of sales | $ | 2,223 | $ | 2,100 | $ | 2,106 | $ | 4,323 | $ | 4,070 | |||||||
Research and development | 10,350 | 9,791 | 9,816 | 20,141 | 18,978 | ||||||||||||
Selling, general and administrative | 5,346 | 5,056 | 5,069 | 10,402 | 9,799 | ||||||||||||
(2) Amortization of debt discount | |||||||||||||||||
(non-cash interest expense) | — | — | 5,524 | — | 10,970 |
LINEAR TECHNOLOGY CORPORATION CONSOLIDATED CONDENSED BALANCE SHEETS (in thousands) U.S. GAAP (unaudited) |
||||||||
December 28, 2014 | June 29, 2014 | |||||||
ASSETS: | ||||||||
Current assets: | ||||||||
Cash, cash equivalents and marketable securities | $ | 1,072,866 | $ | 1,012,787 | ||||
Accounts receivable, net of allowance for doubtful accounts of $1,651 ($1,653 at June 29, 2014) |
148,584 | 173,340 | ||||||
Inventories | 100,141 | 91,310 | ||||||
Deferred tax assets and other current assets | 99,743 | 87,276 | ||||||
Total current assets | 1,421,334 | 1,364,713 | ||||||
Property, plant & equipment, net | 294,529 | 277,080 | ||||||
Other noncurrent assets | 12,685 | 13,785 | ||||||
Total assets | $ | 1,728,548 | $ | 1,655,578 | ||||
LIABILITIES & STOCKHOLDERS’ EQUITY: | ||||||||
Current liabilities: | ||||||||
Accounts payable | $ | 20,017 | $ | 28,221 | ||||
Accrued income taxes, payroll & other accrued liabilities | 102,690 | 141,275 | ||||||
Deferred income on shipments to distributors | 47,083 | 45,619 | ||||||
Total current liabilities | 169,790 | 215,115 | ||||||
Deferred tax and other noncurrent liabilities | 120,266 | 109,094 | ||||||
Stockholders’ equity: | ||||||||
Common stock | 1,989,563 | 1,948,006 | ||||||
Accumulated deficit | (550,813 | ) | (616,992 | ) | ||||
Accumulated other comprehensive loss | (258 | ) | 355 | |||||
Total stockholders’ equity | 1,438,492 | 1,331,369 | ||||||
$ | 1,728,548 | $ | 1,655,578 |
LINEAR TECHNOLOGY CORPORATION CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (In thousands) (unaudited) |
||||||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||||||
December 28,
2014 |
September 28,
2014 |
December 29,
2013 |
December 28,
2014 |
December 29,
2013 |
||||||||||||||||
Cash flow from operating activities: | ||||||||||||||||||||
Net income | $ | 123,602 | $ | 129,459 | $ | 104,751 | $ | 253,061 | $ | 212,619 | ||||||||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||||||||||
Depreciation and amortization | 13,555 | 13,214 | 12,792 | 26,769 | 25,627 | |||||||||||||||
Stock-based compensation | 17,919 | 16,947 | 16,991 | 34,866 | 32,847 | |||||||||||||||
Amortization of convertible senior notes discount | — | — | 5,524 | — | 10,970 | |||||||||||||||
Excess tax benefit from stock-based compensation | (2,548 | ) | (2,202 | ) | (300 | ) | (4,750 | ) | (1,829 | ) | ||||||||||
Change in operating assets and liabilities: | (4,571 | ) | (21,042 | ) | 28,986 | (25,613 | ) | 10,708 | ||||||||||||
Cash provided by operating activities | 147,957 | 136,376 | 168,744 | 284,333 | 290,942 | |||||||||||||||
Cash flow from investing activities: | ||||||||||||||||||||
Net (purchases) and proceeds from sale and maturities of available-for-sale securities | (55,632 | ) | (26,426 | ) | 9,466 | (82,058 | ) | 93,018 | ||||||||||||
Purchase of property, plant and equipment | (16,201 | ) | (26,917 | ) | (4,009 | ) | (43,118 | ) | (7,897 | ) | ||||||||||
Cash (used in) provided by investing activities | (71,833 | ) | (53,343 | ) | 5,457 | (125,176 | ) | 85,121 | ||||||||||||
Cash flow from financing activities: | ||||||||||||||||||||
Excess tax benefit from stock-based compensation | 2,548 | 2,202 | 300 | 4,750 | 1,829 | |||||||||||||||
Issuance of common stock under employee stock plans | 12,092 | 3,323 | 37,861 | 15,415 | 59,516 | |||||||||||||||
Purchase of common stock | (34,709 | ) | (34,086 | ) | (12,182 | ) | (68,795 | ) | (26,853 | ) | ||||||||||
Payment of cash dividends | (65,822 | ) | (65,739 | ) | (62,023 | ) | (131,561 | ) | (124,082 | ) | ||||||||||
Cash used in financing activities | (85,891 | ) | (94,300 | ) | (36,044 | ) | (180,191 | ) | (89,590 | ) | ||||||||||
(Decrease) increase in cash and cash equivalents | (9,767 | ) | (11,267 | ) | 138,157 | (21,034 | ) | 286,473 | ||||||||||||
Cash and cash equivalents, beginning of period | 146,056 | 157,323 | 274,966 | 157,323 | 126,650 | |||||||||||||||
Cash and cash equivalents, end of period | $ | 136,289 | $ | 146,056 | $ | 413,123 | $ | 136,289 | $ | 413,123 |